// Mei-Ling Chan 1 , Chia-Chun Yu 1 , Jui-Ling Hsu 1 , Wohn-Jenn Leu 1 , She-Hung Chan 1 , Lih-Ching Hsu 1 , Shih-Ping Liu 2, 3 , Polina M. Ivantcova 4 , Ozdemir Dogan 5 , Stefan Brase 6, 7 , Konstantin V. Kudryavtsev 4, 8 and Jih-Hwa Guh 1 1 School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan 2 Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan 3 Department of Urology, National Taiwan University Hospital, Taipei, Taiwan 4 Department of Medicinal Chemistry, Faculty of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation 5 Department of Chemistry, Middle East Technical University, Ankara, Turkey 6 Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany 7 Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany 8 Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow region, Russian Federation Correspondence to: Konstantin V. Kudryavtsev, email: kudr@med.chem.msu.ru Jih-Hwa Guh, email: jhguh@ntu.edu.tw Keywords: β-dipeptide, c-Myc, PI3K/Akt, mTOR, hormone-refractory prostate cancer Received: October 21, 2016 Accepted: May 08, 2017 Published: May 20, 2017 ABSTRACT The use of peptides that target cancer cells and induce anticancer activities through various mechanisms is developing as a potential anticancer strategy. KUD983, an enantiomerically pure β-dipeptide derivative, displays potent activity against hormone-refractory prostate cancer (HRPC) PC-3 and DU145 cells with submicromolar IC 50 . KUD983 induced G1 arrest of the cell cycle and subsequent apoptosis associated with down-regulation of several related proteins including cyclin D1, cyclin E and Cdk4, and the de-phosphorylation of RB. The levels of nuclear and total c-Myc protein, which could increase the expression of both cyclin D1 and cyclin E, were profoundly inhibited by KUD983. Furthermore, it inhibited PI3K/Akt and mTOR/p70S6K/4E-BP1 pathways, the key signaling in multiple cellular functions. The transient transfection of constitutively active myristylated Akt (myr-Akt) cDNA significantly rescued KUD983-induced caspase activation but did not blunt the inhibition of mTOR/p70S6K/4E-BP1 signaling cascade suggesting the presence of both Akt-dependent and -independent pathways. Moreover, KUD983-induced effect was enhanced with the down-regulation of anti-apoptotic Bcl-2 members (e.g., Bcl-2, and Mcl-1) and IAP family members (e.g., survivin). Notably, KUD983 induced autophagic cell death using confocal microscopic examination, tracking the level of conversion of LC3-I to LC3-II and flow cytometric detection of acidic vesicular organelles-positive cells. In conclusion, the data suggest that KUD983 is an anticancer β-dipeptide against HRPCs through the inhibition of cell proliferation and induction of apoptotic and autophagic cell death. The suppression of signaling pathways regulated by c-Myc, PI3K/Akt and mTOR/p70S6K/4E-BP1 and the collaboration with down-regulation of Mcl-1 and survivin may explain KUD983-induced anti-HRPC mechanism.